These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17899837)

  • 41. [Lipoprotein glomerulopathy: a case report].
    Han HL; Lin S; Song L; Sun LS; Liang H; Zhao LQ; Zhai DP
    Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):443-4. PubMed ID: 16251059
    [No Abstract]   [Full Text] [Related]  

  • 42. [Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka/Kurashiki variant].
    Yang Z; Wu H; Hu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):166-169. PubMed ID: 32034747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of lipoprotein glomerulopathy in a Greek Caucasian male.
    Marinaki S; Kalaitzakis E; Kolovou K; Gakiopoulou H; Stylianou K; Papasotiriou M; Boletis IN
    Int Urol Nephrol; 2022 Apr; 54(4):969-970. PubMed ID: 34160779
    [No Abstract]   [Full Text] [Related]  

  • 44. A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy.
    Ku M; Tao C; Zhou AA; Cheng Y; Wan QJ
    Chin Med J (Engl); 2019 Jan; 132(2):237-239. PubMed ID: 30614865
    [No Abstract]   [Full Text] [Related]  

  • 45. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants.
    Saito T; Oikawa S; Sato H; Sasaki J
    Nephron; 1999; 83(3):193-201. PubMed ID: 10529625
    [No Abstract]   [Full Text] [Related]  

  • 46. APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.
    Rovin BH; Roncone D; McKinley A; Nadasdy T; Korbet SM; Schwartz MM
    N Engl J Med; 2007 Dec; 357(24):2522-4. PubMed ID: 18077821
    [No Abstract]   [Full Text] [Related]  

  • 47. Restriction isotyping of apoprotein E.
    Sack MN; Hoeg JM
    Ann Intern Med; 1994 Nov; 121(10):816. PubMed ID: 7944063
    [No Abstract]   [Full Text] [Related]  

  • 48. Recurrence of lipoprotein glomerulopathy after renal transplantation.
    Andrews PA; O'Donnell PJ; Dilly SA; Snowden SA; Bewick M
    Nephrol Dial Transplant; 1997 Nov; 12(11):2442-4. PubMed ID: 9394344
    [No Abstract]   [Full Text] [Related]  

  • 49. Lipoprotein glomerulopathy: a new apolipoprotein-E-related disease that recurs after renal transplantation.
    Mourad G; Cristol JP; Turc-Baron C; Djamali A
    Transplant Proc; 1997 Aug; 29(5):2376. PubMed ID: 9270770
    [No Abstract]   [Full Text] [Related]  

  • 50. Case Report: A Pediatric Case of Lipoprotein Glomerulopathy in China and Literature Review.
    Song Y; Yang C; Liu L; Wang H
    Front Pediatr; 2021; 9():684814. PubMed ID: 34513758
    [No Abstract]   [Full Text] [Related]  

  • 51. Glomerular diseases: genetic causes and future therapeutics.
    Chiang CK; Inagi R
    Nat Rev Nephrol; 2010 Sep; 6(9):539-54. PubMed ID: 20644582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 53. [Lipoprotein glomerulopathy].
    Saito T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():112-6. PubMed ID: 17899837
    [No Abstract]   [Full Text] [Related]  

  • 54. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Physiopathology of lipoprotein glomerulopathy].
    Saito T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1838-44. PubMed ID: 17037324
    [No Abstract]   [Full Text] [Related]  

  • 56. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.